介入治疗脑血栓临床疗效分析

Clinical Analysis of Interventional Therapy of Cerebral Thrombosis

目的分析探讨对脑血栓进行阿替普酶溶栓剂介入治疗的临床治疗效果。方法将2015年12月—2016年12月收治的88例脑血栓患者随机分为观察组和对照组,每组44例患者,对观察组患者进行阿替普酶溶栓剂介入治疗,为对照组患者进行阿替普酶静脉溶栓治疗,观察并比较两组患者临床治疗的表现及效果。结果观察组患者的治疗总有效率为81.8%(36/44),对照组患者的治疗总有效率为68.2%(30/44),数据差异有统计学意义(P<0.05);观察组患者颅内出血、颅内未出血以及情况加重的患者分别为1例、3例、1例,对照组则分别为5例、10例、1例,颅内出血情况的数据差异有统计学意义(P<0.05),情况加重的数据差异无统计学意义(P>0.05)。结论对脑血栓病患进行阿替普酶溶栓剂介入治疗的临床治疗效果较好,可显著提升治疗有效率,愈后出血情况较好,具有临床广泛推广价值。

Objective This paper tries to explore the clinical effect of interventional therapy of thalidomide thrombolytic agents on cerebral thrombosis.Methods 88 patients with cerebral thrombosis admitted from December 2015 to December 2016 were randomly divided into the observation group and the control group,with 44 patients in each group.Patients in the observation group were treated with alteplase thrombolytic agent teatment,the control group of patients was treated with alteplase intravenous thrombolytic therapy,and the clinical treatment of the performance and effectiveness of the two groups of patients were observed and compared.Results The total effective rate was 81.8%(36/44)in the observation group and 68.2%(30/44)in the control group.The difference was statistically significant(P<0.05).In the observation group,intracranial hemorrhage,intracranial non-hemorrhage and exacerbation of the patients were of 1 case,3 cases,1 case,and those in the control group were of 5 cases,10 cases,1 case,so there was significant difference in the intracranial hemorrhage data(P<0.05).There was no statistically significant difference between the two groups of the severe situations(P>0.05).Conclusion The clinical treatment of patients with cerebral thrombosis in the treatment of alteplase thrombolytic therapy is better,which can significantly improve the efficiency of treatment,the prognosis of bleeding,with a wide range of clinical value.